The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Human CD56bright NK Cells: An Update
Abstract
Human NK cells can be subdivided into various subsets based on the relative expression of CD16 and CD56. In particular, CD56brightCD16−/dim NK cells are the focus of interest. They are considered efficient cytokine producers endowed with immunoregulatory properties, but they can also become cytotoxic upon appropriate activation. These cells were shown to play a role in different disease states, such as cancer, autoimmunity, neuroinflammation, and infection. Although their phenotype and functional properties are well known and have been extensively studied, their lineage relationship with other NK cell subsets is not fully defined, nor is their precise hematopoietic origin. In this article, we summarize recent studies about CD56bright NK cells in health and disease and briefly discuss the current controversies surrounding them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
CD56bright natural killer (NK) cells: an important NK cell subset
Poli, A., Michel, T., Thérésine, M., Andrès, E., Hentges, F., & Zimmer, J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03027.x · Cited by 977
Self-citationInnate lymphoid cells: A new paradigm in immunology
Eberl, G., Colonna, M., Di Santo, J. P., & McKenzie, A. N. J. (2015) · Science · doi:10.1126/science.aaa6566 · Cited by 878
Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H., Chiang, S. C. C., Foley, B., Mattsson, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.008 · Cited by 787
Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45816 · Cited by 681
Development, Differentiation, and Diversity of Innate Lymphoid Cells
Diefenbach, A., Colonna, M., & Koyasu, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.005 · Cited by 560
Lee, J., Zhang, T., Hwang, I., Kim, A., Nitschke, L., Kim, M., Scott, J. M., Kamimura, Y., Lanier, L. L., & Kim, S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.013 · Cited by 552
Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Chalifour, A., Jeannin, P., Gauchat, J.-F., Blaecke, A., Malissard, M., N'Guyen, T., Thieblemont, N., & Delneste, Y. (2004) · Blood · doi:10.1182/blood-2003-08-2820 · Cited by 351
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Delahaye, N. F., Rusakiewicz, S., Martins, I., Ménard, C., Roux, S., Lyonnet, L., Paul, P., Sarabi, M., Chaput, N., Semeraro, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2366 · Cited by 341
Gineau, L., Cognet, C., Kara, N., Lach, F. P., Dunne, J., Veturi, U., Picard, C., Trouillet, C., Eidenschenk, C., Aoufouchi, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61014 · Cited by 307
Dalbeth, N., Gundle, R., Davies, R. J. O., Lee, Y. C. G., McMichael, A. J., & Callan, M. F. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6418 · Cited by 307
Wynn, D., Kaufman, M., Montalban, X., Vollmer, T., Simon, J., Elkins, J., O'Neill, G., Neyer, L., Sheridan, J., Wang, C., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70033-8 · Cited by 301
Carlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., & Malmberg, K.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901226 · Cited by 283
Brenu, E. W., van Driel, M. L., Staines, D. R., Ashton, K. J., Ramos, S. B., Keane, J., Klimas, N. G., & Marshall-Gradisnik, S. M. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-81 · Cited by 251
Ottaviani, C., Nasorri, F., Bedini, C., de Pità, O., Girolomoni, G., & Cavani, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535243 · Cited by 248
Hudspeth, K., Donadon, M., Cimino, M., Pontarini, E., Tentorio, P., Preti, M., Hong, M., Bertoletti, A., Bicciato, S., Invernizzi, P., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.011 · Cited by 246
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Boomer, J. S., Shuherk-Shaffer, J., Hotchkiss, R. S., & Green, J. M. (2012) · Critical Care · doi:10.1186/cc11404 · Cited by 243
Yu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I.-K., Liu, S., McClory, S., Marcucci, G., Trotta, R., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215491 · Cited by 235
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset
Mace, E. M., Hsu, A. P., Monaco-Shawver, L., Makedonas, G., Rosen, J. B., Dropulic, L., Cohen, J. I., Frenkel, E. P., Bagwell, J. C., Sullivan, J. L., et al. (2013) · Blood · doi:10.1182/blood-2012-09-453969 · Cited by 233
Vacca, P., Vitale, C., Montaldo, E., Conte, R., Cantoni, C., Fulcheri, E., Darretta, V., Moretta, L., & Mingari, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016257108 · Cited by 226
NKG2D ligands as therapeutic targets.
(2013) · Europe PMC (PubMed Central) · Cited by 218
Hao, J., Liu, R., Piao, W., Zhou, Q., Vollmer, T. L., Campagnolo, D. I., Xiang, R., La Cava, A., Van Kaer, L., & Shi, F.-D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092749 · Cited by 213
A subset of natural killer cells is greatly expanded within inflamed joints
Dalbeth, N., & Callan, M. F. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10410 · Cited by 210
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis
Söderström, K., Stein, E., Colmenero, P., Purath, U., Müller-Ladner, U., Teixeira de Matos, C., Tarner, I. H., Robinson, W. H., & Engleman, E. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000546107 · Cited by 196
Wu, C., Li, B., Lu, R., Koelle, S. J., Yang, Y., Jares, A., Krouse, A. E., Metzger, M., Liang, F., Loré, K., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.020 · Cited by 186
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Pesce, S., Tabellini, G., Cantoni, C., Patrizi, O., Coltrini, D., Rampinelli, F., Matta, J., Vivier, E., Moretta, A., Parolini, S., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1001224 · Cited by 178
Nielsen, N., Ødum, N., Ursø, B., Lanier, L. L., & Spee, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031959 · Cited by 172
Teunissen, C., Menge, T., Altintas, A., Álvarez-Cermeño, J. C., Bertolotto, A., Berven, F. S., Brundin, L., Comabella, M., Degn, M., Deisenhammer, F., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513488232 · Cited by 167
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer
Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S., & Whiteside, T. L. (2003) · European Journal of Immunology · doi:10.1002/immu.200390014 · Cited by 164
CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
Béziat, V., Duffy, D., Nguyen, S., Garff‐Tavernier, M. L., Decocq, J., Combadière, B., Debré, P., & Vieillard, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100330 · Cited by 162
Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis
Jiang, W.-Z., Chai, N., Marić, D., & Bielekova, B. (2011) · Journal of Immunology · doi:10.4049/jimmunol.1100789 · Cited by 152
Human natural killer cell development in secondary lymphoid tissues
Freud, A. G., Yu, J., & Caligiuri, M. A. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.008 · Cited by 150
Practical NK cell phenotyping and variability in healthy adults
Angelo, L. S., Banerjee, P. P., Monaco-Shawver, L., Rosen, J. B., Makedonas, G., Forbes, L. R., Mace, E. M., & Orange, J. S. (2015) · Immunologic Research · doi:10.1007/s12026-015-8664-y · Cited by 147
Signatures of Human NK Cell Development and Terminal Differentiation
Luetke-Eversloh, M. V., Killig, M., & Romagnani, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00499 · Cited by 146
Natural killer–cell differentiation by myeloid progenitors
Grzywacz, B. J., Kataria, N., Kataria, N., Blazar, B. R., Miller, J. S., & Verneris, M. R. (2010) · Blood · doi:10.1182/blood-2010-04-281394 · Cited by 146
Ali, T. H., Pisanti, S., Ciaglia, E., Mortarini, R., Anichini, A., Garofalo, C., Tallerico, R., Santinami, M., Gulletta, E., Ietto, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6639 · Cited by 145
Hervier, B., Béziat, V., Haroche, J., Mathian, A., Lebon, P., Ghillani‐Dalbin, P., Musset, L., Debré, P., Amoura, Z., & Vieillard, V. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30313 · Cited by 144
Toll-like receptors expression and interferon-γ production by NK cells in human sepsis
Souza-Fonseca-Guimarães, F., Parlato, M., Philippart, F., Misset, B., Cavaillon, J., Adib‐Conquy, M., & the Captain study group (2012) · Critical Care · doi:10.1186/cc11838 · Cited by 142
Han, S., Lin, Y. C., Wu, T., Salgado, A. D., Mexhitaj, I., Wuest, S. C., Romm, E., Ohayon, J. M., Goldbach‐Mansky, R. T., Vanderver, A. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302884 · Cited by 141
Morandi, F., Horenstein, A. L., Chillemi, A., Quarona, V., Chiesa, S., Imperatori, A. S., Zanellato, S., Mortara, L., Gattorno, M., Pistoia, V., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500591 · Cited by 140
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets
Mamessier, É., Pradel, L. C., Thibult, M., Drevet, C., Zouine, A., Jacquemier, J. D., Houvenaeghel, G. F., Bertucci, F., Birnbaum, D., & Olive, D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200140 · Cited by 137
Characterization of tumor infiltrating Natural Killer cell subset
Levi, I., Amsalem, H., Nissan, A., Darash‐Yahana, M., Peretz, T., Mandelboim, O., & Rachmilewitz, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3453 · Cited by 136
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome
Rusakiewicz, S., Nocturne, G., Lazure, T., Semeraro, M., Flament, C., Caillat‐Zucman, S., Sène, D., Delahaye, N., Vivier, É., Chaba, K., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005727 · Cited by 129
An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2–Driven Activation of CD56bright NK Cells
Martin, J. F., Perry, J. S. A., Jakhete, N., Wang, X., & Bielekova, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902238 · Cited by 126
The Finnish Multiple Sclerosis and Pregnancy Study Group, Airas, L. M., Saraste, M., Rinta, S., Elovaara, I., Huang, Y.-H., & Wiendl, H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03555.x · Cited by 121
NK Cells in Central Nervous System Disorders
Poli, A., Kmiecik, J., Domingues, O., Hentges, F., Bléry, M., Chekenya, M., Boucraut, J., & Zimmer, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203401 · Cited by 115
Self-citationBelisle, J. A., Gubbels, J. A. A., Raphael, C. A., Migneault, M., Rancourt, C., Connor, J. P., & Patankar, M. S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02660.x · Cited by 110
Milush, J. M., Long, B. R., Snyder-Cappione, J. E., Cappione, A., York, V. A., Ndhlovu, L. C., Lanier, L. L., Michaëlsson, J., & Nixon, D. F. (2009) · Blood · doi:10.1182/blood-2009-04-216374 · Cited by 106
Messaoudene, M., Fregni, G., Fourmentraux-Neves, E., Chanal, J., Maubec, E., Mazouz-Dorval, S., Couturaud, B., Girod, A., Sastre‐Garau, X., Albert, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1303 · Cited by 106
Human Cytokine-Induced Memory-Like Natural Killer Cells
Berrien-Elliott, M. M., Wagner, J. A., & Fehniger, T. A. (2015) · Journal of Innate Immunity · doi:10.1159/000382019 · Cited by 105
Takahashi, E., Kuranaga, N., Satoh, K., et al. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01883.x · Cited by 103
Schierloh, P., Yokobori, N. K., Alemán, M., Musella, R. M., Bompadre, M. B., Saab, M. A., Alves, L., Abbate, E. H., de la Barrera, S., & Sasiain, M. D. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6852 · Cited by 100
Intrathecal effects of daclizumab treatment of multiple sclerosis
Bielekova, B., Richert, N. D., Herman, M. L., Ohayon, J. M., Waldmann, T. A., McFarland, H. F., Martinꝉ, R., & Blevins, G. (2011) · Neurology · doi:10.1212/wnl.0b013e318239f7ef · Cited by 94
Epigenetic regulation of NK cell differentiation and effector functions
Cichocki, F. M., Miller, J. S., Anderson, S. K., & Bryceson, Y. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00055 · Cited by 93
Therapeutic Advances and Treatment Options in Metastatic Melanoma
Johnson, D. B., & Sosman, J. A. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0565 · Cited by 91
de Matos, C. T., Berg, L., Michaëlsson, J., Felländer‐Tsai, L., Kärre, K., & Söderström, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02638.x · Cited by 89
Natural killer cells and their receptors in multiple sclerosis.
Kaur, G., Trowsdale, J., & Fugger, L. (2013) · Brain : a journal of neurology · doi:10.1093/brain/aws159 · Cited by 83
Zingoni, A., Ardolino, M., Santoni, A., & Cerboni, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00408 · Cited by 81
Batoni, G., Esin, S., Favilli, F., Pardini, M., Bottai, D., Maisetta, G., Florio, W., & Campa, M. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01692.x · Cited by 78
Stabile, H., Nisti, P., Morrone, S., Pagliara, D., Bertaina, A., Locatelli, F., Santoni, A., & Gismondi, A. (2015) · Haematologica · doi:10.3324/haematol.2014.116053 · Cited by 78
Hao, J., Campagnolo, D. I., Liu, R., Piao, W., Shi, S. X.-Y., Hu, B., Xiang, R., Zhou, Q., Vollmer, T. L., Kaer, L. V., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22339 · Cited by 78
Diversification and Functional Specialization of Human NK Cell Subsets
Cichocki, F. M., Schlums, H., Theorell, J., Tesi, B., Miller, J. S., Ljunggren, H., & Bryceson, Y. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_487 · Cited by 78
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
Škarica, M., Eckstein, C. P., Whartenby, K. A., & Calabresi, P. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.02.010 · Cited by 73
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
Martinꝉ, R. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.10.008 · Cited by 71
Ahern, D., & Brennan, F. (2011) · Immunology Letters · doi:10.1016/j.imlet.2010.11.001 · Cited by 70
Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis
Rodríguez‐Martín, E., Picón, C., Costa‐Frossard, L., Alenda, R., de la Maza, S. S., Quirós-Roldán, E., Espiño, M., Villar, L. M., & Alvarez-Cermeño, J. C. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12580 · Cited by 68
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies
Conigliaro, P., Scrivo, R., Valesini, G., & Perricone, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.017 · Cited by 68
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
Rodríguez, J., López‐Botet, M., Munteis, E., Río, J., Roquer, J., Montalbán, X., & Comabella, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.006 · Cited by 66
Mrakovčić-Šutić, I., Tokmadžić, V. S., Laškarin, G., Mahmutefendić, H., Lučin, P., Župan, Ž., & Šustić, A. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02407.x · Cited by 65
Sánchez-Correa, B., Campos, C., Pera, A., Bergua, J., Arcos, M. J., Bañas, H., Casado, J., Morgado, S., Durán, E., Solana, R., et al. (2016) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-015-1720-6 · Cited by 62
Johnson, T., Evans, B. L., Durafourt, B. A., Blain, M., Lapierre, Y., Bar‐Or, A., & Antel, J. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003823 · Cited by 61
Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways
Tanaka, S. (2013) · World Journal of Orthopedics · doi:10.5312/wjo.v4.i1.1 · Cited by 58
Almeida, I., Silva, S. V., Fonseca, A. R., Silva, I., Vasconcelos, C., & Lima, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8505-8 · Cited by 56
CD56 bright natural killer cells and response to daclizumab HYP in relapsing-remitting MS
Elkins, J. S., Sheridan, J. P., Amaravadi, L. S., Riester, K. A., Selmaj, K. W., Bielekova, B., Parr, E., & Giovannoni, G. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000065 · Cited by 53
Klöß, S., Chambron, N., Gardlowski, T., Arseniev, L., Koch, J., Esser, R., Glienke, W., Seitz, O., & Koehl, U. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1055993 · Cited by 51
Sheridan, J. P., Zhang, Y., Riester, K. A., Tang, M. T., Efros, L., Shi, J. D., Harris, J. M., Vexler, V. S., & Elkins, J. S. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511414755 · Cited by 50
Luci, C., Gaudy‐Marqueste, C., Rouzaire, P., Audonnet, S., Cognet, C., Hennino, A., Nicolas, J., Grob, J., & Tomasello, E. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10814.x · Cited by 49
Wulff, S., Pries, R., Börngen, K., Trenkle, T., & Wollenberg, B. (2009) · PubMed · Cited by 49
Vacca, P., Martini, S., Garelli, V., Passalacqua, G., Moretta, L., & Mingari, M. C. (2012) · European Journal of Immunology · doi:10.1002/eji.201242783 · Cited by 44
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
Lin, Y. C., Winokur, P. N., Blake, A., Wu, T., Romm, E., & Bielekova, B. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.181 · Cited by 43
Watanabe, M., Kono, K., Kawaguchi, Y., Mizukami, Y., Mimura, K., Maruyama, T., Izawa, S., & Fujii, H. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01073.x · Cited by 43
Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations
Maciejewski‐Duval, A., Meuris, F., Bignon, A., Aknin, M.-L. R., Balabanian, K., Faivre, L. O., Pasquet, M., Barlogis, V., Fieschi, C., Bellanné‐Chantelot, C., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ma0815-388r · Cited by 39
Delineation of Natural Killer Cell Differentiation from Myeloid Progenitors in Human
Chen, Q., Ye, W., Tan, W. J., Yong, K. S. M., Liu, M., Tan, S. Q., Loh, E., Chang, K. T. E., Tan, T. C., Preiser, P. R., et al. (2015) · Scientific Reports · doi:10.1038/srep15118 · Cited by 39
Hardcastle, S. L., Brenu, E., Johnston, S., Nguyen, T. U., Huth, T. K., Ramos, S. B., Staines, D., & Marshall‐Gradisnik, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0653-3 · Cited by 36
Holtan, S. G., Creedon, D. J., Thompson, M. A., Nevala, W. K., & Markovic, S. N. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/316314 · Cited by 34
Lukešová, Š., Vroblova, V., Tošner, J., Kopecký, J., Sedláková, I., Čermáková, E., Vokurková, D., & Kopecký, O. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.54388 · Cited by 34
Weiss, I. D., Shoham, H., Wald, O., Wald, H., Beider, K., Abraham, M., Barashi, N., Galun, E., Nagler, A., & Peled, A. (2011) · Cytokine · doi:10.1016/j.cyto.2011.01.011 · Cited by 32
Reinhardt, R., Pohlmann, S., Kleinertz, H., Hepner-Schefczyk, M., Paul, A., & Flohé, S. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130155 · Cited by 28
Huth, T. K., Brenu, E. W., Ramos, S. B., Nguyen, T. M., Broadley, S., Staines, D., & Marshall‐Gradisnik, S. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12388 · Cited by 28
Ernste, F. C., Crowson, C. S., de Padilla, C. M. L., Hein, M. S., & Reed, A. M. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121031 · Cited by 18
Mehling, M., Burgener-Gasser, A.-V., Brinkmann, V., Bantug, G. R., Dimeloe, S., Höenger, G., Kappos, L., & Hess, C. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12347 · Cited by 17
Seaward, A., Burke, S. D., Ramshaw, H., Smith, G. N., & Croy, B. A. (2011) · Human Reproduction · doi:10.1093/humrep/der114 · Cited by 13
Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
Tallerico, R., Cristiani, C. M., Capone, M., Madonna, G., Mallardo, D., Simeone, E., Dominijanni, A., Grimaldi, A. M., Colucci, F., Ascierto, P. A., et al. (2015) · Journal of Translational Medicine · doi:10.1186/1479-5876-13-s1-o8 · Cited by 8
No Monkeying Around: Clonal Tracking of Stem Cells and Progenitors in the Macaque
Dykstra, B. J., & Bystrykh, L. V. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.03.006 · Cited by 5
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
The Broad Spectrum of Human Natural Killer Cell Diversity
Freud, A. G., Mundy-Bosse, B. L., Yu, J., & Caligiuri, M. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.008 · Cited by 695
NK cells and type 1 innate lymphoid cells: partners in host defense
Spits, H., Bernink, J. H., & Lanier, L. (2016) · Nature Immunology · doi:10.1038/ni.3482 · Cited by 443
Engineering IL-2 for immunotherapy of autoimmunity and cancer
Hernandez, R., Põder, J., LaPorte, K. M., & Malek, T. R. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00680-w · Cited by 355
Vari, F., Arpon, D., Keane, C., Hertzberg, M. S., Talaulikar, D., Jain, S., Cui, Q., Han, E., Tobin, J., Bird, R., et al. (2018) · Blood · doi:10.1182/blood-2017-07-796342 · Cited by 313
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C., Arcos-Burgos, M., & Lidbury, B. (2019) · Diagnostics · doi:10.3390/diagnostics9030091 · Cited by 313
Metadata
- Authors
- Michel, T., Poli, A., Cuapio, A., Briquemont, B., Iserentant, G., Ollert, M., & Zimmer, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-01
- Volume
- 196
- Issue
- 7
- Pages
- 2923-2931
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2301758340
- Cited by
- 395
- References
- 98
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.